A phase 1 study of ATTR-01, a novel oncolytic adenovirus targeting αvβ6 integrin, which expresses an anti-PD-L1 antibody in tumors following IV delivery in patients with selected epithelial cancers

ATTR-01 - Accession Therap

https://jitc.bmj.com/content/13/Suppl_2/A656

Adel Samson 1; Emiliano Calvo 2; Tatiana Hernandez 3; Magdalena Meissner 4; Victor Moreno 5; Eileen Parkes 6; Pavlina Spiliopoulou 7; Pia Donaldson 8; Julia DeCesare 9; David Krige 10; Hardev Pandha 11

Oct 3, 2025